We previously revealed that the treatment of cervical cancer cells with LMB, an exportin-1 inhibitor, prevents the nuclear export of HP1γ, and thus, suppresses the expression of UBE2L3 while promoting p53 signaling [15]. Here, UBE2L3 is linked to cervical carcinoma.